Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Cell autonomous role of iASPP deficiency in causing cardiocutaneous disorders.

Dedeić Z, Sutendra G, Hu Y, Chung K, Slee EA, White MJ, Zhou FY, Goldin RD, Ferguson DJP, McAndrew D, Schneider JE, Lu X.

Cell Death Differ. 2018 Jul;25(7):1289-1303. doi: 10.1038/s41418-017-0039-6. Epub 2018 Jan 19.

PMID:
29352264
2.

Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB.

Hu Y, Ge W, Wang X, Sutendra G, Zhao K, Dedeić Z, Slee EA, Baer C, Lu X.

Oncotarget. 2015 Dec 15;6(40):42478-90. doi: 10.18632/oncotarget.6478.

3.

iASPP, a previously unidentified regulator of desmosomes, prevents arrhythmogenic right ventricular cardiomyopathy (ARVC)-induced sudden death.

Notari M, Hu Y, Sutendra G, Dedeić Z, Lu M, Dupays L, Yavari A, Carr CA, Zhong S, Opel A, Tinker A, Clarke K, Watkins H, Ferguson DJ, Kelsell DP, de Noronha S, Sheppard MN, Hollinshead M, Mohun TJ, Lu X.

Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):E973-81. doi: 10.1073/pnas.1408111112. Epub 2015 Feb 17.

4.

Emerin inhibits Lmo7 binding to the Pax3 and MyoD promoters and expression of myoblast proliferation genes.

Dedeic Z, Cetera M, Cohen TV, Holaska JM.

J Cell Sci. 2011 May 15;124(Pt 10):1691-702. doi: 10.1242/jcs.080259. Epub 2011 Apr 26.

5.

Mechanisms of corneal tissue cross-linking in response to treatment with topical riboflavin and long-wavelength ultraviolet radiation (UVA).

McCall AS, Kraft S, Edelhauser HF, Kidder GW, Lundquist RR, Bradshaw HE, Dedeic Z, Dionne MJ, Clement EM, Conrad GW.

Invest Ophthalmol Vis Sci. 2010 Jan;51(1):129-38. doi: 10.1167/iovs.09-3738. Epub 2009 Jul 30.

Supplemental Content

Loading ...
Support Center